These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 9234808)

  • 21. Human CD4+ T cells induced by synthetic peptide malaria vaccine are comparable to cells elicited by attenuated Plasmodium falciparum sporozoites.
    Calvo-Calle JM; Oliveira GA; Nardin EH
    J Immunol; 2005 Dec; 175(11):7575-85. PubMed ID: 16301667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epitope mapping of PfCP-2.9, an asexual blood-stage vaccine candidate of Plasmodium falciparum.
    Li C; Wang R; Wu Y; Zhang D; He Z; Pan W
    Malar J; 2010 Apr; 9():94. PubMed ID: 20384992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking Vaccines.
    Espinosa DA; Vega-Rodriguez J; Flores-Garcia Y; Noe AR; Muñoz C; Coleman R; Bruck T; Haney K; Stevens A; Retallack D; Allen J; Vedvick TS; Fox CB; Reed SG; Howard RF; Salman AM; Janse CJ; Khan SM; Zavala F; Gutierrez GM
    Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27895131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity of Plasmodium falciparum and Plasmodium vivax circumsporozoite protein repeat multiple antigen constructs (MAC).
    Udhayakumar V; Saekhou A; Fang S; Jue D; Wohlhueter RM; Lal AA
    Vaccine; 1998; 16(9-10):982-8. PubMed ID: 9682348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB2 in malaria exposed individuals.
    Nguyen TV; Sacci JB; de la Vega P; John CC; James AA; Kang AS
    Malar J; 2009 Oct; 8():235. PubMed ID: 19852802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge.
    Calvo-Calle JM; Oliveira GA; Watta CO; Soverow J; Parra-Lopez C; Nardin EH
    Infect Immun; 2006 Dec; 74(12):6929-39. PubMed ID: 17030584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibodies of three different immunoglobulin G isotypes produced by immunization with a synthetic peptide or native protein protect mice against challenge with Plasmodium yoelii sporozoites.
    Ak M; Bower JH; Hoffman SL; Sedegah M; Lees A; Carter M; Beaudoin RL; Charoenvit Y
    Infect Immun; 1993 Jun; 61(6):2493-7. PubMed ID: 8500885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of protective immune responses by immunization with linear multiepitope peptides based on conserved sequences from Plasmodium falciparum antigens.
    Bharadwaj A; Sharma P; Joshi SK; Singh B; Chauhan VS
    Infect Immun; 1998 Jul; 66(7):3232-41. PubMed ID: 9632590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies against thrombospondin-related anonymous protein do not inhibit Plasmodium sporozoite infectivity in vivo.
    Gantt S; Persson C; Rose K; Birkett AJ; Abagyan R; Nussenzweig V
    Infect Immun; 2000 Jun; 68(6):3667-73. PubMed ID: 10816526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmodium falciparum sporozoite immunization protects against Plasmodium berghei sporozoite infection.
    Sina BJ; do Rosario VE; Woollett G; Sakhuja K; Hollingdale MR
    Exp Parasitol; 1993 Sep; 77(2):129-35. PubMed ID: 8375482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteolytic Cleavage of the Plasmodium falciparum Circumsporozoite Protein Is a Target of Protective Antibodies.
    Espinosa DA; Gutierrez GM; Rojas-López M; Noe AR; Shi L; Tse SW; Sinnis P; Zavala F
    J Infect Dis; 2015 Oct; 212(7):1111-9. PubMed ID: 25762791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity and in vitro protective efficacy of a recombinant multistage Plasmodium falciparum candidate vaccine.
    Shi YP; Hasnain SE; Sacci JB; Holloway BP; Fujioka H; Kumar N; Wohlhueter R; Hoffman SL; Collins WE; Lal AA
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1615-20. PubMed ID: 9990073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
    Dobaño C; Doolan DL
    Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunization of Malaria-Preexposed Volunteers With PfSPZ Vaccine Elicits Long-Lived IgM Invasion-Inhibitory and Complement-Fixing Antibodies.
    Zenklusen I; Jongo S; Abdulla S; Ramadhani K; Lee Sim BK; Cardamone H; Flannery EL; Nguyen T; Fishbaugher M; Steel RWJ; Betz W; Carmago N; Mikolajczak S; Kappe SHI; Hoffman SL; Sack BK; Daubenberger C
    J Infect Dis; 2018 Apr; 217(10):1569-1578. PubMed ID: 29438525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity of well-characterized synthetic Plasmodium falciparum multiple antigen peptide conjugates.
    Joshi MB; Gam AA; Boykins RA; Kumar S; Sacci J; Hoffman SL; Nakhasi HL; Kenney RT
    Infect Immun; 2001 Aug; 69(8):4884-90. PubMed ID: 11447164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo inhibition of malaria parasite infection by monoclonal antibodies against Plasmodium falciparum circumsporozoite protein (CSP).
    Livingstone MC; Bitzer AA; Giri A; Luo K; Sankhala RS; Choe M; Zou X; Dennison SM; Li Y; Washington W; Ngauy V; Tomaras GD; Joyce MG; Batchelor AH; Dutta S
    Sci Rep; 2021 Mar; 11(1):5318. PubMed ID: 33674699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A highly infectious Plasmodium yoelii parasite, bearing Plasmodium falciparum circumsporozoite protein.
    Zhang M; Kaneko I; Tsao T; Mitchell R; Nardin EH; Iwanaga S; Yuda M; Tsuji M
    Malar J; 2016 Apr; 15():201. PubMed ID: 27068454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of Plasmodium falciparum parasite-inhibitory antibodies by immunization with recombinantly-expressed CyRPA.
    Favuzza P; Blaser S; Dreyer AM; Riccio G; Tamborrini M; Thoma R; Matile H; Pluschke G
    Malar J; 2016 Mar; 15():161. PubMed ID: 26979066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P. falciparum and P. vivax Epitope-Focused VLPs Elicit Sterile Immunity to Blood Stage Infections.
    Whitacre DC; Espinosa DA; Peters CJ; Jones JE; Tucker AE; Peterson DL; Zavala FP; Milich DR
    PLoS One; 2015; 10(5):e0124856. PubMed ID: 25933001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens.
    Bettencourt P
    Front Immunol; 2020; 11():190. PubMed ID: 32153565
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.